The CSDH Grading Scheme for Middle Meningeal Artery Embolization: Stratified Risk of Surgical Rescue.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 42423595.
- Also identified by DOI 10.1227/neu.0000000000004156.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prospective stratification of surgical rescue risk after middle meningeal artery embolization (MMAE) for chronic subdural hematomas (CSDHs) can facilitate a follow-up approach and optimize patient expectations. In this study, we have identified factors, identifiable at the time of presentation, for MMAE failure in a summative fashion using a grading scheme. The scheme includes 4 domains defined on presentation (1 point for each): Coagulation/platelet abnormality, Scan findings (midline shift >6 mm, hemispheric hematoma with thickness ≥15 mm, or acute components), Deficits (attributable focal neurological deficits [FNDs]), History (comorbidities requiring antithrombotic agents during the reabsorption of hematomas), making up "CSDH." The predictive performance for risk of surgical rescue was assessed using calibration curve and C-index in an institutional cohort. In a test dataset of 100 cases, its accuracy was further compared with 2 regression models. Of 298 CSDHs undergoing stand-alone MMAE, 9.4% required surgical rescue (n = 28): 5.4% if Grade 1 (0-1 point, 87% cases), 29% if Grade 2 (2 points, 11% of cases), and 67% if Grade 3 (3 points or more, 2% of cases). The CSDH score demonstrated both external accuracy and discrimination (C-index 0.81, 95% CI 0.74-0.87). Accuracy persisted in the test data (area under the receiver-operating characteristic curves [AUROC] 0.85, 95% CI 0.74-0.95) compared with a least absolute shrinkage and selection operator regression model (FNDs, hemispheric hematoma, acute component, midline shift >6 mm, age, and hemodialysis; AUROC 0.79, 95% CI 0.66-0.92, P = .46) and a logistic regression model (FNDs, hemispheric hematoma, acute component, and thrombocytopenia; AUROC 0.75, 95% CI 0.61-0.89, P = .22). Comprehensive assessment of CSDH imaging features, neurological deficits, and predisposing hemorrhagic factors may delineate appropriate candidates for stand-alone MMAE.